Skip to content

A study for the effect of intake of lactic acid bacteria on visceral fat, body fat, abdominal CT visual analysis

A study for the effect of intake of lactic acid bacteria on visceral fat, body fat, abdominal CT visual analysis - A study for the effect of intake of lactic acid bacteria on visceral fat, body fat, abdominal CT visual analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041194
Enrollment
66
Registered
2021-11-29
Start date
2020-07-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Sponsors

TTC Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females from 20 to 64 years of age (2) Subjects whose BMI is 23 kg / m^2 or more and less than 30 kg / m^2. (3) The average blood pressure, triglycerides, HDL-cholesterol, and blood glucose of the entire intake initiator are considered to be within the reference range of each item

Exclusion criteria

Exclusion criteria: (1)Subjects who regularly ingest food, health food or medicine rich in lactic acid bacteria or natto bacteria (2)Subjects who are regularly ingest health food or medicine that affects body fat and lipid metabolism (3)Subjects who are judged to be unsuitable for research from the results of screening test pre-examination (4)Subjects who always use laxative when defecation (5)Subjects who have taken antibiotics within 3 months before fecal sampling (6)Subjects whose feces are unsuitable for research (7)Subjects who are judged to be unsuitable for the study based on the results of clinical laboratory test or cardiopulmonary function (8)Subjects who have been possibilities for emerging allergy related to the study (9)Subjects who are on a diet at the time of screening testpre-examination (10)Subjects who have diseases requiring regular administration, or who have severe diseases (11)Subjects who are judged to be unsuitable for the study based on the results of clinical laboratory test or physical examination (12)Subjects who are judged to be unsuitable for the study based on the results of lifestyle questionnaire (13)Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (14)Subjects who plan to get pregnant or nurse a baby during this study (15)Subjects judged as unsuitable for the study by the investigator

Design outcomes

Primary

MeasureTime frame
Evaluate abdominal visceral fat area and waist circumference when taking the test food continuously for 12 weeks

Secondary

MeasureTime frame
Evaluate body weight, BMI, total cholesterol, triacylglyceride, HDL-cholesterol, LDL-cholesterol, body fat percentage and muscle mass, abdominal CT (subcutaneous fat area, visceral fat area, psoas major muscle area), perimeter (neck, chest, arms, thighs, hips), subcutaneous fat thickness (chest, arms, thighs) when taking the test food continuously for 12 weeks

Countries

Japan

Contacts

Public ContactKyohei Hashimoto

TTC Co., Ltd. Clinical Research Planning Department

k.hashimoto@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026